ATAI Life Sciences

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.

Crowdstrike,Sign,And,Logo,At,Headquarters,In,Silicon,Valley.,Crowdstrike

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ASAN

ATAI

CRWD

DOCS

MRUS

QDEL

CrowdStrike, Asana And Other Big Stocks Moving Lower In Wednesday&#39;s Pre-Market Session

Will,Psilocybin,Truffles,And,Magic,Mushrooms,Be,The,Future,For

Cannabis

Psychedelics

Politics

CMPS

CYBN

MNMD

PSIL

SEEL

Psychedelics litigator Matthew Zorn joins HHS under RFK Jr. to lead policy. What it means for CMPS, MNMD, CYBN, PSIL &amp; more.

Ex-Gov&#39;t Foe Joins Trump, RFK Jr.&#39;s HHS To Lead Psychedelics Policy: What It Means For Investors

Stock Movers

ASPN

FSLY

LION

LPRO

PEGA

RDDT

Trade Desk Posts Downbeat Revenue, Joins Aspen Aerogels, Fastly And Other Big Stocks Moving Lower In Thursday&#39;s Pre-Market Session

ATAI Life Sciences NV

Press Releases

atai Life Sciences Announces First Patient Dosed in Elumina, the Phase 2 Clinical Trial of VLS-01 for Treatment-Resistant Depression

Earnings

atai Life Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights

atai Life Sciences Announces First Patient Dosed in Phase 2 Study of EMP-01 for the Treatment of Social Anxiety Disorder

atai Life Sciences Reports First Quarter 2025 Financial Results and Recent Corporate Updates

General

atai Life Sciences Announces Positive Topline Data from Part 2 of Beckley Psytech's Phase 2a Study of BPL-003 in Combination with SSRIs for Treatment-Resistant Depression

atai Life Sciences to Participate in Upcoming Investor Conferences

Financing

atai Life Sciences and Beckley Psytech to Combine Creating a Global Leader in Psychedelic Mental Health Therapies

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BPMC, STRM, ATAI, STR on Behalf of Shareholders

ATAI Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of Atai Life Sciences N.V. is Fair to Shareholders

Legal

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LNSR, ATAI, ICAD on Behalf of Shareholders

BPMC

ICAD

LNSR

STRM

HC Wainwright & Co.

Canaccord Genuity

Maxim Group

EF Hutton

Credit Suisse

Screenshot 2024-05-21 at 6.46.56 PM

Biotech

SILO

FTRP

Revolutionizing Mental Healthcare With The Rise Of Ketamine And Psychedelic Therapies

Comments

ATAI Life Sciences

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell